The Clinicopathological Features of DNMT3A R882 Mutant Myeloid Neoplasms

被引：0
|
作者：
Jawad, Majd [1 ]
Zheng, Gang [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
LABORATORY INVESTIGATION | 2021年 / 101卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
704
引用
收藏
页码：847 / 847
页数：1
相关论文
共 50 条
  • [21] Prognostic Impact of FLT3-ITD and DNMT3A R882 Double Mutations in Patients with Acute Myeloid Leukemia
    Tang, Shanhao
    Tang, Xiaowen
    Shen, Hongjie
    Xue, Shengli
    Wang, Tingjing
    Lu, Jing
    Yin, Jia
    Wu, Depei
    BLOOD, 2016, 128 (22)
  • [22] Novel Therapeutic Targets for DNMT3A Mutant Myeloid Neoplasms
    Adema, Vera
    Balasubramanian, Suresh K.
    Hirsch, Cassandra M.
    Przychodzen, Bartlomiej P.
    Phillips, James G.
    Lindner, Daniel
    Radivoyevitch, Tomas
    Mukherjee, Sudipto
    Nazha, Aziz
    Carraway, Hetty E.
    Sole, Francesc
    Sekeres, Mikkael A.
    Visconte, Valeria
    Maciejewski, Jaroslaw P.
    BLOOD, 2017, 130
  • [23] DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation
    Jawad, Majd
    Afkhami, Michelle
    Ding, Yi
    Zhang, Xiaohui
    Li, Peng
    Young, Kim
    Xu, Mina Luqing
    Cui, Wei
    Zhao, Yiqing
    Halene, Stephanie
    Al-Kali, Aref
    Viswanatha, David
    Chen, Dong
    He, Rong
    Zheng, Gang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation
    Jawad, Majd
    Afkhami, Michelle
    Ding, Yi
    Zhang, Xiaohui
    Li, Peng
    Xu, Mina
    Cui, Wei
    Kim, Young
    Halene, Stephanie
    Viswanatha, David
    He, Rong
    Chen, Dong
    Zheng, Gang
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 962 - 964
  • [25] Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia
    Bhatnagar, Bhavana
    Eisfeld, Ann-Kathrin
    Nicolet, Deedra
    Mrozek, Krzysztof
    Blachly, James S.
    Orwick, Shelley
    Lucas, David M.
    Kohlschmidt, Jessica
    Blum, William
    Kolitz, Jonathan E.
    Stone, Richard M.
    Bloomfield, Clara D.
    Byrd, John C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (02) : 226 - 236
  • [26] Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients
    Yuan, Xiao-Qing
    Chen, Peng
    Du, Yin-Xiao
    Zhu, Ke-Wei
    Zhang, Dao-Yu
    Yan, Han
    Liu, Han
    Liu, Yan-Ling
    Cao, Shan
    Zhou, Gan
    Zeng, Hui
    Chen, Shu-Ping
    Zhao, Xie-Lan
    Yang, Jing
    Zeng, Wen-Jing
    Chen, Xiao-Ping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [27] DNMT3A genetic polymorphisms predict disease prognosis in R882 mutation negative AML patients
    YUAN Xiao-qing
    ZHNG Dao-yu
    YAN Han
    YANG Yong-long
    ZHU Ke-wei
    ZHOU Hong-hao
    ZENG Hui
    CHEN Xiao-ping
    中国药理学与毒理学杂志, 2016, (10) : 1067 - 1067
  • [28] Rapid detection of DNMT3A R882 codon mutations allows early identification of poor risk patients with acute myeloid leukemia
    Brewin, John N.
    Horne, Gillian A.
    Bisling, Kathrin E.
    Stewart, Helen J.
    Chevassut, Timothy J.
    LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1336 - 1339
  • [29] Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients
    Xiao-Qing Yuan
    Peng Chen
    Yin-Xiao Du
    Ke-Wei Zhu
    Dao-Yu Zhang
    Han Yan
    Han Liu
    Yan-Ling Liu
    Shan Cao
    Gan Zhou
    Hui Zeng
    Shu-Ping Chen
    Xie-Lan Zhao
    Jing Yang
    Wen-Jing Zeng
    Xiao-Ping Chen
    Journal of Translational Medicine, 17
  • [30] Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns
    Emperle, Max
    Adam, Sabrina
    Kunert, Stefan
    Dukatz, Michael
    Baude, Annika
    Plass, Christoph
    Rathert, Philipp
    Bashtrykov, Pavel
    Jeltsch, Albert
    NUCLEIC ACIDS RESEARCH, 2019, 47 (21) : 11355 - 11367
12345